Screener
Pediatrix Medical Group MD Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Pediatrix Medical Group in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Pediatrix Medical Group’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204993
FAQ
- What is Pediatrix Medical Group's cash & equivalents?
- Pediatrix Medical Group (MD) reported cash & equivalents of $205.78M in Q1 2026.
- How has Pediatrix Medical Group's cash & equivalents changed year-over-year?
- Pediatrix Medical Group's cash & equivalents increased by 107.9% year-over-year, from $98.98M to $205.78M.
- What is the long-term trend for Pediatrix Medical Group's cash & equivalents?
- Over 5 years (2020 to 2025), Pediatrix Medical Group's cash & equivalents has grown at a -19.7% compound annual growth rate (CAGR), from $1.12B to $375.24M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Pediatrix Medical Group's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude